Itoh, M et al. Nat. Commun. 10, 2244 (2019)
Recent developments in stem cell technology and tissue engineering have opened new avenues for regenerative medicine. Tissues and organs such as vascular grafts, liver, and myocardium have been successfully produced from human-derived cells and implanted in small animals. However, before translation to the clinics, human cell regeneration strategies need to be evaluated in large animals. A study describes a new mini-pig model in which an immunodeficient state was induced by removing the major immune organs and administrating immunosuppressive therapy. This operational immunodeficient pig (OIDP) model enabled the long-term accommodation of an artificial human vascular graft that was rejected in a conventional immunosuppressive pig (CISP) model. OIDPs might become an invaluable tool for the evaluation of preclinical human cell regeneration strategies.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Le Bras, A. A new immunodeficient pig model. Lab Anim 48, 198 (2019). https://doi.org/10.1038/s41684-019-0339-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41684-019-0339-1